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Background. To chart the epidemiology of primary glomeru-
lar disease by means of a prospective regional study in the south-
ern part of The Netherlands.
Methods. Experienced renal technicians collected renal biop-
sies, blood, and 24-hour urine samples at the bed site in each
of the participating hospitals. The material was processed and
analyzed at the University Hospital Maastricht. Analysis in-
cluded light microscopy, immunohistochemistry, and electron
microscopy of the biopsies as well as serologic and chemical
analysis.
Results. Primary IgA nephropathy (IgAN), membra-
nous glomerulopathy, antineutrophil cytoplasmic antibody
(ANCA)-associated glomerulonephritis and thin basement
membrane nephropathy (TBMN) are the most common pri-
mary glomerular diseases in this order of sequence. Our data
show the clinical and histologic phenotype of TBMN to be
diverse: the vast majority of TBMN has chronic microscopic
hematuria, frequently associated with hypertension in late mid-
dle age; about 15% of TBMN has in addition substantial pro-
teinuria which is associated in the majority of cases with the
lesions of focal segmental glomerulosclerosis (FSGS). In 5% of
TBMN a nephrotic syndrome is observed, occasionally associ-
ated with FSGS tip lesions.
Conclusion. These results support the notion that TBMN is
a disease of genetic heterogeneity; it is not a benign renal con-
dition in a substantial number of patients, particularly those in
late middle age.
In 1978, the regional nephrology working group, Lim-
burg, was created in order to study prospectively the
epidemiology and natural history of idiopathic, mostly
immunologically mediated, glomerular disease in adults
[1]. One of the objectives was to identify risk factors
for the progression of primary renal disease toward end-
stage renal failure.
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To date, the registry contains kidney biopsies and
serum and urine collections from an estimated stable
adult adherent population in the southern part of The
Netherlands. Participating centers are the city hospitals
of Heerlen, Roermond, and Sittard as well as the Univer-
sity Hospital Maastricht, which all have a dialysis unit and
are consequently referral centers for general practition-
ers. The regional approach avoids the concentration of
patients with an unfavorable prognosis in academic cen-
ters and thus provides a reliable overview of prevailing
primary renal disease in this part of The Netherlands.
METHODS
Patients were derived from an epidemiologic, regional
study carried out between 1978 and 2003 and designed
to chart the incidence and natural history of idiopathic
glomerular disease [1]. Three hospitals located in the
south of Limburg participated up to 1986, whereas from
1986 on, all four hospitals of south and middle Limburg
collaborated in this project, thus increasing the adherent
population by 20%. The general hospitals were located
within 40 miles of the University Hospital Maastricht.
Renal biopsies were taken on the basis of the following
indications in order of hierarchy as follows: recent onset
uremia (serum creatinine concentration >300 lmol/L)
and recent onset nephrotic syndrome (NS) (24-hour uri-
nary protein excretion ≥5 g). Recent onset implied that
biopsies were taken within 6 months of patient identifi-
cation. The other indications in hierarchical order were
erythrocyturia with proteinuria in excess of 1 g/day in the
presence of mild uremia (serum creatinine concentration
>120 <300 lmol/L), isolated proteinuria (24-hour uri-
nary protein excretion over 1 g/day), and erythrocyturia
of the chronic microscopic and/or recurrent macroscopic
variety; the latter signs had to be present at least 6 months
prior to renal biopsy.
Renal biopsies, blood and 24-hour urine collections
were harvested in each of the hospitals by experienced
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technicians from the University Hospital Maastricht. One
biopsy was snap frozen in liquid nitrogen at the biopsy
site and stored at −80◦C. A second biopsy was processed
for light microscopy and ultrastructural analysis. Section-
ing and staining of thin sections for light microscopy,
immunohistochemistry, and ultrastructural analysis was
done as described previously [1]. Blood was collected at
37◦C at the bedside and allowed to clot for 60 minutes at
37◦C and centrifuged at 37◦C; serum thus obtained was
stored at 4◦C for 5 days; cryoglobulins, if any, were re-
dissolved in 0.9% saline at 37◦C, washed, and analyzed
for composition. Another aliquot of blood was allowed to
clot on ice for 2 hours and next used for serologic studies
and stored at −80◦C.
Urine was concentrated via dialysis/ultrafiltration
(Hollow fiber cartridge, type H, P10-20; Amicon Divi-
sion, WR Grace and Co., Beverly, MA, USA) against
distilled water, frozen and dried, and stored at −80◦C.
Renal biopsies were classified according to the World
Health Organization (WHO) criteria of 1995 with some
modifications [2]. The lesions of focal segmental glomeru-
losclerosis (FSGS) were classified according to Korbet [3]
and Noe¨l [4] into the tip, perihilar, “classical,” and the col-
lapsing varieties. Thus the proliferative variety was con-
sidered to be an early form of the classical lesion and as
such presented in this paper. The diagnosis of primary
FSGS required the absence of systemic disease or other
primary renal disease. In the presence of reduced re-
nal mass the lesions of FSGS were considered secondary
[5]. The presence of hypertension and/or chronic micro-
scopic hematuria, however, was considered compatible
with primary FSGS [2]. End-stage renal disease (ESRD)
was diagnosed when >80% of the glomeruli were scle-
rotic/fibrotic provided ten or more glomeruli per sec-
tion were present; thus, biopsies containing less than ten
glomeruli per section were considered insufficient mate-
rial. Fibrotic/sclerotic glomeruli in the range of 30% to
80% were, in the absence of clear-cut cause, classified
as global glomerulosclerosis. Renal biopsies containing
fewer than six glomeruli/section were considered as tech-
nical failures [even if an etiologic diagnosis (e.g., amyloi-
dosis or IgA nephropathy could be made)].
Thin basement membrane disease (TBMN) was di-
agnosed as described previously [6]. It required the
presence of a glomerular basement membrane (GBM)
<260 nm with a unimodal distribution using the orthog-
onal intercept method and the absence of IgA deposits
by immunohistochemistry; extrarenal disease had to be
absent and the presence of “Goodpasture-type antigen”
using monoclonal antibody against the collagen part of
the a5 chain of type IV collagen on fresh frozen sections
was required [7]. When the GBM was lamellated, split,
lacked the a5 collagen IV chain, or had a bimodal distri-
bution, patients were classified in the “GBM pathology,
others” category.
In all patients with pauci-immune crescentic
glomerulonephritis, antineutrophil cytoplasmic an-
tibody (ANCA) testing was performed in serums
collected at the time of biopsy, and retrospectively in
serums from those patients with crescentic, non-IgA
glomerulonephritis whose biopsies (and serums) were
harvested in the pre-ANCA era.
RESULTS
Table 1 shows an overview of prevailing renal disease
over the last 25 years, divided into two time periods; 1978
until 1990 and from 1990 until 2003, respectively. A 20%
increase in the number of patients (renal biopsies) oc-
curred when 1978 to 1990 is compared with 1990 to 2003,
due to the participation of a fourth hospital in the second
period. The number of biopsies per year taken in each
hospital remained fairly constant over the studied period.
In the second period a substantial decrease in the number
of biopsies showing normal renal tissue was observed as
compared to the early years (80 versus 19). In most cases
the indication for these biopsies had been microscopic
or recurrent macroscopic erythrocyturia; however, in the
early years persisting for only 6 months, whereas later on
it had to be present for 2 years, provided urologic workup
was normal.
Patients presenting with nonproteinuric (less than 1 g/
day), nonazotemic erythrocyturia usually appeared to
have TBMN (N = 71). Of these 71 patients 49 were nor-
motensive (systolic blood pressure 121 ± 14 mm Hg and
diastolic blood pressure 76 ± 7 mm Hg), and 22 were
hypertensive (systolic blood pressure 148 ± 14 mm Hg
and diastolic blood pressure 93 ± 9 mm Hg, P < 0.05).
The hypertensive patients were older (52 ± 12 years vs.
35.2 ± 14.5 years). Interestingly, in both subgroups there
was already proteinuria in the microalbuminuric range,
however, not significantly different between the two sub-
groups. Renal function did also not differ between the
two groups (serum creatinine 91 ± 24 umol/L and 86 ±
20 umol/L, respectively, NS).
In case chronic, nonazotemic erythrocyturia was asso-
ciated with proteinuria (more than 1 g/day) patients usu-
ally had IgA nephropathy particularly when they were of
the male gender.
Membranous glomerulopathy stage 1, minimal lesion
glomerulopathy, and primary FSGS were the most com-
mon causes of nonazotemic NS in this order of de-
creasing incidence. Of the 58 patients with minimal
lesion glomerulopathy, eight had microscopic erythrocy-
turia which was associated with TBMN in three patients.
Of the patients with primary FSGS and NS (N = 36),
nine had microscopic hematuria which was associated
with TBMN in two. Of the patients with primary FSGS
and chronic proteinuria (N = 28), 13 had microscopic
hematuria which was associated with a TBMN in nine
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Table 1. Limburg kidney biopsies: General overview
Indication Number of biopsies GenderAge Serum creatinine Urinary protein
Diagnosis E P EP EPu NS U Total 77 to 90 91 to 03 years M F lmol/L g/24 hours
Thin GBM (TBMN) 71 0 12 4 5 0 92 38 54 40 ± 2 45 47 89 ± 3 1.0 ± 0.2
Minimal change 0 0 0 0 58 5 63 24 39 43 ± 2 38 25 137 ± 19 8.2 ± 0.7
GBM pathology, others 6 0 5 0 1 3 15 10 5 36 ± 4 9 6 142 ± 30 1.7 ± 0.5
IgA nephropathy 19 1 75 16 21 16 148 64 84 41 ± 1 110 38 160 ± 10 2.8 ± 0.2
IgA nephropathy, secondary 5 0 10 2 2 3 22 12 10 50 ± 4 17 5 190 ± 45 3.4 ± 0.9
Henoch Schonlein GN 0 0 8 2 9 2 21 7 14 48 ± 5 13 8 145 ± 21 5.0 ± 1.0
Primary FSGS 0 15 4 0 36 0 55 22 32 46 ± 2 33 21 117 ± 7 6.1 ± 0.5
Membranous GP 0 11 7 0 109 4 131 53 78 50 ± 1 89 42 111 ± 8 8.0 ± 0.5
Mesangial proliferative GP 3 0 5 1 5 0 14 5 9 48 ± 5 13 1 133 ± 15 4.8 ± 1.7
Membranoproliferative GN 1 0 9 2 14 3 29 12 17 46 ± 4 12 17 164 ± 14 5.6 ± 0.8
ANCA-associated crescentic GN 6 0 24 11 6 76 123 46 77 59 ± 1 90 33 411 ± 24 2.5 ± 0.2
aGBM crescentic GN 1 0 0 0 1 14 16 7 9 54 ± 5 9 7 571 ± 180 2.7 ± 0.3
SLE 7 3 27 1 14 3 55 21 34 34 ± 2 10 45 111 ± 8 2.7 ± 0.3
Postinfectious GN 4 0 9 2 8 6 29 17 12 41 ± 3 18 11 185 ± 24 3.3 ± 0.7
Cryoglobulinemia type II 1 0 4 0 4 2 11 5 6 66 ± 4 3 8 207 ± 48 4.2 ± 0.6
Intra- and/or extracapillary GN 0 0 2 0 3 2 7 3 4 58 ± 7 5 2 232 ± 40 3.5 ± 0.7
Interstitial nephritis 9 13 9 7 7 30 75 32 43 52 ± 2 49 26 303 ± 27 2.3 ± 0.4
ATN 0 0 0 0 0 8 8 2 6 55 ± 5 4 4 543 ± 102 0.4 ± 0.1
Hypertension/arteriosclerosis 1 21 8 3 3 17 53 37 16 53 ± 2 33 20 307 ± 37 1.4 ± 0.2
Amyloidosis 0 4 0 0 24 5 33 13 20 60 ± 2 17 16 155 ± 22 8.9 ± 1.0
Scarred kidney 0 2 0 0 1 13 16 7 9 46 ± 3 11 5 576 ± 80 3.4 ± 0.5
Global glomerulosclerosis 2 2 2 4 5 5 20 8 12 42 ± 5 11 9 196 ± 31 2.8 ± 0.5
Normal kidney 61 18 20 0 0 0 99 80 19 36 ± 1 63 36 89 ± 3 0.6 ± 0.1
Insufficient material 13 11 9 5 16 21 75 39 36 50 ± 2 46 29 236 ± 22 3.1 ± 0.3
Miscellaneous 138 50 88
Abbreviations are: E, erythrocyturia; P, proteinuria; EP, erythrocyturia and proteinuria >1 g/day but <5 g/day; EPu, erythrocyturia and proteinuria and serum
creatinine concentration >120 <300 lmol/L; NS, nephrotic syndrome, U, uremia; M, male; F, female; GBM, glomerular basement membrane; TBMN, thin basement
membrane nephropathy, GN, glomerulonephritis; FSGS, focal segmental glomerulosclerosis; GP, glomerulopathy; ANCA, antineutrophil cytoplasmic antibody; SLE,
systemic lupus erythematosus; ATN, acute tubular necrosis.
instances (Table 2). Thus, of the 22 patients originally
classified as primary FSGS with microscopic hematuria
50% turned out to be secondary FSGS due to TBMN.
Interestingly, 5% of the patients with TBMN had the NS
which was associated with glomerular tip lesions in two.
Of the patients with TBMN and substantial proteinuria
(N = 16), nine had FSGS which was of the perihilar va-
riety in five and of the classical variety in four (Table 3);
this was associated with hypertension in eight out of nine
cases and with an increase in serum creatinine concentra-
tion in two.
Of the patients with recent onset uremia, ANCA-
positive crescentic glomerulonephritis was the most
common cause followed by interstitial nephritis. These
interstitial nephritides were multifactorial and included
Hanta virus infections and hypersensitivity reactions to
drugs particularly in male patients. In the registry 123
patients were diagnosed with ANCA-associated vasculi-
tis and glomerulonephritis; 55 patients were positive for
proteinase-3 (PR3)-ANCA, 63 patients for myeloperox-
idase (MPO)-ANCA, whereas four patients had both
PR3- and MPO-ANCA.
DISCUSSION
Health policy changes made during the period of ob-
servation do influence the study of epidemiology. Thus in
Table 2. Incidence of thin basement membrane nephropathy
(TBMN) in adult “primary” focal segmental glomerulosclerosis
(FSGS)
Indication for renal biopsy
P PE NS NS/E
Type of lesion
Tip lesion 1 — 12 6 (2)
Perihilar 6 9 (5) 3 2
Classical 7 4 (4) 12 1
Collapsing 1 — 2 —
Total 15 13 (9) 29 9 (2)
Numbers within parentheses refer to TBMN; Abbrevations are: P, 24-hour
urinary protein excretion >1 g/day and <5 g/day; PE, proteinuria > 1 g/day and
microscopic erythrocyturia; NS, nephrotic syndrome (24-hour proteinuria > 5 g;
NS/E, nephrotic syndrome and microscopic erythrocyturia.
spite of an increase of the number of biopsies with TBMN
taken because of nonproteinuric microscopic hematuria
in the period 1990 to 2003, as compared to 1978 to
1990, the number of renal biopsies taken from histo-
logically normal kidneys decreased markedly (Table 1).
This decrease was brought about by a “wait and see” at-
titude, In the 1990 to 2003 period renal biopsies from
young adults with chronic microscopic hematuria were
taken after about a 2-year waiting period instead of the
6-month period during the first study period [8]. Also,
after 1990 urinary sediments were examined for dysmor-
phic erythrocytes thus allowing differentiation between
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Table 3. Signs and symptoms of thin glomerular basement membrane (GBM) nephropathy
Indication for renal biopsy
E EP EPu NS/E
Number of biopsies 71 12 4 5
Age years 40.3 ± 15.8 41.2 ± 26.6 50.7 ± 12.8 41.4 ± 15.5
Serum creatinine lmol/L 87.7 ± 21.1 76.1 ± 17.8 160.1 ± 36.2 86.2 ± 13.4
P systolic mm Hg 129.1 ± 18.4 140.4 ± 22.5 150.1 ± 14.7 147.0 ± 19.2
P diastolic mm Hg 81.2 ± 10.8 89.5 ± 7.5 92.5 ± 8.6 86.1 ± 8.9
U protein mg/24 hours 206 ± 156 1830 ± 889 1501 ± 312 7959 ± 3051
FSGS
Tip lesion 2
Perihilar 4 1
Classic 3 1
Abbrevations are: E, chronic erythrocyturia; EP, erythrocyturia and proteinuria >1 g/day but <5 g/day; EPu, erythrocyturia and proteinuria and serum cre-
atinine concentration >120 <300 lmol/L; NS/E, nephrotic syndrome/erythrocyturia and proteinuria >5 g/day; P, ∗∗∗∗; U, ∗∗∗∗; FSGS, focal segmental glomerulosclerosis.
macroscopic hematuria of nephrologic and urologic
origin [8]. The incidence of diabetic nephropathy is
undoubtedly greater than reported in this paper since
proteinuric patients with diabetic retinopathy (by fluo-
rescence and light microscopy) were considered to have
diabetic nephropathy and were, in most cases, not sub-
jected to renal biopsy. Also worthy of note is the decrease
in hypertensive nephropathy in the period 1990 to 2003 in
spite of an increase in the number of biopsies, which could
have been brought about by more strict antihypertensive
patient care.
The present data confirm the results of a previous
prospective regional study carried out between 1978
and 1986. The incidence of TBMN exceeds that of IgA
nephropathy in adults presenting with nonproteinuric
hematuria [6]. It shows in addition that the majority
of patients with microscopic hematuria and FSGS have
underlying TBMN. It has recently become clear that
the differentiation between autosomal-dominant TBMN
and heterozygous carriers of autosomal-recessive Alport
syndrome may be difficult [9]. Carriers of autosomal-
recessive Alport and X linked Alport may have uni-
formly thin basement membranes and mutations in
the Col4A3/Col4A4 and Col A5 genes, respectively. In
TBMN mutations in the Col4A4 genes have by described
by the group of Buzza et al [10], thus confirming the sug-
gestion that some cases of TBMN may in fact be heterozy-
gotic carriers of autosomal-recessive Alport [9]. Hence,
we may have included in our population instances of com-
pound heterozygotes (both parents a mutation) or just
heterozygotes (one parent) for autosomal-recessive Al-
port since family analysis was not done on all our patients
and because we have not (yet) examined them for muta-
tions in the Col4 genes.
That TBMN is not necessarily benign is again illus-
trated in this study by the observation that 15% of the pa-
tients with TBMN, usually middle-aged patients, present
with substantial proteinuria, microscopic hemauria, hy-
pertension, and global glomerulosclerosis up to 30% of
the total number of glomeruli in the absence of overt
renal failure [11]. Since autosomal-recessive Alport is a
heterogeneous disorder that has been found to be as-
sociated with TBMN and premature glomerulosclerosis,
it is clear that we cannot differentiate on the basis of
clinical, immunohistochemical, and histopathologic phe-
notype TBMN from heterozygous carriers of autosomal-
recessive Alport [12]. Interestingly a NS was present in
five of the TBMN patients that was in two associated with
glomerular tip lesions. Toma, Wang, and Savige [13] have
shown recently that some adults with TBMN and pro-
teinuria up to 500 mg/day have either mutations in the
NPHS2 gene identified in familial FSGS or alternatively
have R229Q polymorphism. None of our patients with
TBMN appeared related and there was no evidence of a
familial NS. Our results support the notion that TBMN is
a disease of genetic heterogeneity; it is not a benign renal
condition in a substantial number of patients, particularly
those in late middle age.
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